Clinical Trials Browser

NCT01025089 2026-01-07

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

Phase 2 Active not recruiting

18 enrolled

Thoracic

Thymoma

NCT06101394 2024-01-25

RECOGNISE

Phase 2 Unknown

25 enrolled

Thoracic

Lung Neoplasms

NCT03727724 2023-10-18

AFACET

Phase 2 Completed

37 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00103207 2023-06-28

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

Phase 2 Completed

72 enrolled 9 charts

Thoracic

Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02716311 2022-08-11

ACE-Lung

Phase 2 Completed

118 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03717155 2022-06-06

Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC

Phase 2 Completed

43 enrolled 18 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01059188 2022-03-11

Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

69 enrolled

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01102231 2021-02-16

Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)

Phase 2 Completed

106 enrolled 13 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00870870 2018-06-01

A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before

Phase 2 Completed

64 enrolled 20 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00519831 2017-06-09

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

Phase 2 Terminated

18 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00996567 2017-02-09

MesoMab

Phase 2 Completed

22 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Neoplasms

NCT00842712 2017-01-13

CERTO

Phase 2 Completed

232 enrolled 17 charts

Thoracic

Metatropic dwarfism, Carcinoma, Non-Small-Cell Lung

NCT00874848 2016-11-29

Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

90 enrolled 20 charts

Thoracic

NSCLC

NCT00117962 2016-10-07

Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase 2 Completed

109 enrolled 12 charts

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00124618 2016-07-06

Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Phase 2 Completed

58 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01109524 2015-12-24

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

Phase 2 Completed

72 enrolled 15 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00081302 2015-11-17

Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Phase 2 Completed

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00112346 2015-10-28

Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

120 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00673738 2015-10-08

Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)

Phase 2 Completed

27 enrolled 8 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00368992 2015-09-14

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

110 enrolled 8 charts

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

NCT00867009 2015-06-15

A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer

Phase 2 Completed

113 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00986674 2014-09-26

Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

140 enrolled 9 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00406302 2014-04-29

Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)

Phase 2 Completed

41 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00203931 2014-03-31

Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer

Phase 2 Terminated

55 enrolled 10 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00118183 2013-06-04

Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

62 enrolled

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT00193453 2012-11-13

Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

69 enrolled 9 charts

Thoracic

Lung Neoplasms

NCT00085501 2012-11-01

S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2 Completed

242 enrolled

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00694603 2012-09-06

Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy

Phase 2 Terminated

56 enrolled 6 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00330746 2012-05-18

CALC-1

Phase 2 Completed

100 enrolled

Thoracic

Advanced Non-Small Cell Lung Cancer

NCT00998101 2012-03-06

Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy

Phase 2 Withdrawn

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00115518 2011-08-05

Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00315185 2010-09-23

Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer

Phase 2 Completed

53 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00063388 2010-04-12

Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer

Phase 2 Completed

66 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Cerebral Palsy, Neoplasms

NCT00097214 2010-04-09

Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

57 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00097227 2010-04-09

Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

165 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00251498 2008-08-21

Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

82 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00561054 2007-11-20

Coimbra

Phase 2 Unknown

47 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung